Free Web Hosting Provider - Web Hosting - E-commerce - High Speed Internet - Free Web Page
Search the Web

FDA approved drugs in other branches

Cardiovascular Recent history My Files History of medicine 1 Custom 4 Pain TTT Big QUESTIONS History of medicine 3 Guest Book What is new in medicine? History of medicine 2 Stethoscpe Blog History of ECG FDA app. drugs Milestones in Cardiology



Drugs Approved in 2008

  • Moxatag (amoxicillin); For the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics; MiddleBrooke Pharmaceuticals; Approved January 2008

Drugs Approved in 2007

  • Evamist (estradiol); For the treatment of moderate to severe vasomotor symptoms due to menopause; Vivus; Approved July 2007
  • Evista (raloxifene hydrochloride); For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women; Eli Lilly; Approved September 2007
  • Altabax (retapamulin); For the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes; Glaxo; Approved April 2007
  • Extina (ketoconazole); For the treatment of seborrheic dermatitis; Stiefel; Approved June 2007

Drugs Approved in 2006

  • Verdeso (desonide); For the treatment of atopic dermatitis; Connetics; Approved September 2006

Drugs Approved in 2005

  • Naglazyme (galsulfase); For the treatment of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome); BioMarin Pharmaceuticals; Approved May 2005

Drugs Approved in 2004

  • Cymbalta (duloxetine); For the treatment of major depressive disorder; Eli Lilly; Approved August 2004
  • Campral (acamprosate calcium); For the treatment of alcohol dependence and the maintenance of alcohol abstinence; Forest Laboratories; Approved August, 2004
  • Macugen (pegaptanib); For the treatment of wet age-related macular degeneration.; Pfizer / Eyetech Pharmaceuticals; Approved December 2004
  • EstroGel (estradiol gel 0.06%); For the treatment of vasomotor symptoms and vulvar and vaginal atrophy associated with menopause; Solvay Pharmaceuticals; Approved April 2004

Drugs Approved in 2003

  • Aldurazyme (laronidase); For the treatment of Mucopolysaccharidosis I (MPS I) in subjects aged 5 to 65; Genzyme; Approved May 2003
  • Boniva (ibandronate); For the treatment and prevention of osteoporosis; Roche / GlaxoSmithKline; Approved May, 2003 -- UPDATED: NEW FORMULATION APPROVED MARCH, 2005
  • Somavert (pegvisomant); Injectable formulation for the treatment of acromegaly; Pharmacia; Approved March 2003
  • Velcade (bortezomib); Injectable agent for the treatment of multiple myeloma patients who have received at least two prior therapies.; Millennium Pharmaceuticals; Approved May 2003
  • Amevive (alefacept); For moderate to severe chronic plaque psoriasis.; Biogen; Approved January 2003

Drugs Approved in 2002

  • Alora; Transdermal patch for the prevention of postmenopausal osteoporosis and treatment of vasomotor menopausal symptoms; Watson Pharmaceuticals; Approved April 2002
  • Avinza (morphine sulfate); Extended release capsule for the relief of pain requiring continuous, around-the-clock therapy; Elan; Approved March 2002
  • Forteo (teriparatide); For the treatment of Osteoporosis in postmenopausal women and men who are at high risk for a fracture.; Eli Lilly; December 2002
  • Remicade; Intravenous infusion for the treatment of rheumatoid arthritis; Centocor; Approved February 2002
  • Testim; External cream for the treatment of male hormone deficiency.; Auxilium Pharmaceuticals; Approved October 2002
  • Vioxx (rofecoxib); For the treatment of rheumatoid arthritis; Merck; Approved April 2002 -- UPDATED: WITHDRAWN OCTOBER 2004
  • Vivelle-Dot (estradiol transdermal system); For the prevention of post-menopausal osteoporosis; Novartis; Approved May 2002
  • Abilify (aripiprazole); Oral drug for the treatment of schizophrenia; Bristol-Myers Squibb, Otsuka America Pharmaceutical; Approved November 2002
  • Geodon (ziprasidone mesylate); To control agitated behavior and psychotic symptoms in schizophrenia patients; Pfizer; Approved June 2002
  • Lexapro (escitalopram oxalate); An orally administered selective serotonin reuptake inhibitor useful for the treatment for major depressive disorder; Forest Laboratories; Approved August 2002
  • Paxil CR; Oral tablet for the treatment of depression and panic disorder; GlaxoSmithKline; Approved February 2002
  • Ritalin LA (methylphenidate HCl); Oral capsules for the treatment Attention-Deficit/Hyperactivity Disorder (ADHD); Novartis; Approved June 2002
  • Strattera (atomoxetine HCl); For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents and adults.; Eli Lilly; December 2002
  • Subutex/Suboxone (buprenorphine/naloxone); Oral tablets for the treatment of opiate dependence; Reckitt Benckiser; Approved October 2002
  • Zoloft (sertraline HCl); Oral tablets for the treatment of premenstrual dysphoric mood disorder (PMDD); Pfizer; Approved May 2002
  • Mesnex; Oral tablet to inhibit the hemorrhagic cystitis induced by Ifex (ifosfamide); Bristol-Myers Squibb, Baxter Healthcare; Approved March 2002
  • Alora; Transdermal patch for the prevention of postmenopausal osteoporosis and treatment of vasomotor menopausal symptoms; Watson Pharmaceuticals; Approved April 2002
  • Bravelle (urofollitropin for injection, purified); Human-derived follicle-stimulating hormone (hFSH) for use in ovulation induction for the treatment of infertility.; Ferring Pharmaceuticals; Approved May 2002
  • Forteo (teriparatide); For the treatment of Osteoporosis in postmenopausal women and men who are at high risk for a fracture.; Eli Lilly; December 2002
  • Vivelle-Dot (estradiol transdermal system); For the prevention of post-menopausal osteoporosis; Novartis; Approved May 2002

Drugs Approved in 2001

  • Genotropin (somatropin); For the treatment of growth failure in children who were born small for gestational age (SGA); Pharmacia; Approved July 2001
  • Kineret; Injectable therapy for the treatment of rheumatoid arthritis; Amgen; Approved November 2001
  • Supartz; Joint fluid therapy for treatment of osteoarthritis in the knee; Smith & Nephew Orthopaedics; Approved January 2001
  • Adderall XR; Once-daily medication for the treatment of attention deficit/hyperactivity disorder (ADHD); Shire Pharmaceuticals; Approved October 2001
  • Focalin (dexmethylphenidate HCl); For the treatment of attention deficit hyperactivity disorder (ADHD); Celgene; Approved November 2001
  • Metadate CD; Oral capsules for the treatment of attention deficit hyperactivity disorder; Celltech Pharmaceuticals; Approved April 2001
  • Prozac Weekly (fluoxetine HCl); For the treatment of depression; Eli Lilly; Approved February 2001
  • Remeron SolTab (mirtazapine); Orally disintegrating tablet for the treatment of depression; Organon; Approved January 2001
  • Bextra; Oral tablet for the treatment of osteoarthritis, rheumatoid arthritis and menstrual pain; Pharmacia, Pfizer; Approved November 2001
  • Femara (letrozole) Tablets; First-line treatment of postmenopausal women with locally advanced or metastatic breast cancer; Novartis; Approved January 2001
  • Invanz; Once-daily injectable treatment for bacterial infections; Merck; Approved November 2001
  • Monistat 3 (miconazole nitrate); Emulsion, cream for the treatment of vaginal yeast infections; Advanced Care Products; Approved February 2001
  • NuvaRing; Monthly vaginal ring for birth control; Organon; Approved October 2001
  • Ortho Evra; Transdermal patch for contraception; Ortho-McNeil Pharmaceutical; Approved November 2001
  • Elidel; Topical cream for the treatment of atopic dermatitis; Novartis; Approved December 2001
  • Estrostep (ethinyl estradiol and norethindrone acetate); For the treatment of moderate acne vulgaris; Pfizer; Approved July 2001
  • Finevin; Topical cream for the treatment of mild to moderate inflammatory acne vulgaris; Berlex Laboratories; Approved May 2001
  • Invanz; Once-daily injectable treatment for bacterial infections; Merck; Approved November 2001
  • Lamisil Solution, 1%; Topical treatment for tinea (pityriasis) versicolor, althete's foot, jock itch, and ringworm; Novartis; Approved March 2001

Drugs Approved in 2000

  • Activella (Estradiol/Norethindrone Acetate) Tablets; Combination hormone replacement therapy for the prevention of osteoporosis and other symptoms associated w/postmenopause; Novo Nordisk; Approved April 2000
  • Mobic (meloxicam) Tablets; For relief of the signs and symptoms of osteoarthritis; Boehringer Ingelheim; Approved April 2000
  • Myobloc; Injectable solution for the treatment of abnormal head position and neck pain associated with cervical dystonia; Elan; Approved December 2000
  • Concerta; For the treatment of Attention Deficit Hyperactivity Disorder; Alza; Approved August 2000
  • Vivelle; For the prevention of postmenopausal osteoporosis; Novartis; Approved August 2000

Drugs Approved in 1999

  • Evista; Osteoporosis treatment; Eli Lilly; Approved September 1999
  • Femhrt Tablets; Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg); Parke-Davis; October 15, 1999
  • Effexor; Treatment for generalized anxiety disorder; Wyeth-Ayerst Laboratories; Approved March 1999
  • Paxil CR Tablets; Treatment for depression; SmithKline Beecham; Approved March 1999
  • Sonata; Treatment fo insomnia; American Home Products; Approved August 1999
  • Raplon; Adjunct to general anesthesia during surgical procedures; Organon; Approved August 1999
  • Ethyol (amifostine); Treatment for xerostomia (dry mouth) due to radiation; U.S. Bioscience, Alza; Approved June 1999
  • Alamast; pemirolast potassium ophthalmic solution; Santen; Approved September 1999
  • ZADITOR; Treatment for the prevention of itching of the eye; Ciba Vision; Approved July 1999
  • Aromasin Tablets; Exemestane Tablets, 25 mg; Pharmacia & Upjohn; October 21, 1999
  • Cenestin; Treatment for symptoms associated with menopause; Duramed Pharmaceuticals; Approved July 1999
  • Cenestin; Treatment for relief of vasomotor symptoms due to menopause; Duramed Pharmaceuticals; Approved March 1999
  • Cleocin; Treatment for bacterial vaginosis; Pharmacia & Upjohn; Approved August 1999
  • Climara; For the prevention of postmenopausal osteoporosis (loss of bone mass); Berlex Laboratories; Approved June 1999
  • Doxil (doxorubicin HCl liposome injection); Treatment for ovarian cancer that is refractory to other first-line therapies; Alza; Approved June 1999
  • Ellence; epirubicin hydrochloride; Pharmacia & Upjohn; Approved September 1999
  • Estradiol Transdermal System; Transdermal patch system for the treatement of vulvar vaginal atrophy and vasomotor symptoms.; Wyeth-Ayerst Laboratories; Approved September 1999
  • Femhrt Tablets; Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg); Parke-Davis; October 15, 1999
  • Lupron Depot; Treatment for endometriosis and uterine fibroids; TAP Pharmaceuticals; Approved June 1999
  • Ortho-Prefest; 17 beta estradiol/17 beta estradiol norgestimate tablets; Ortho-McNeil Pharmaceutical, R.W. Johnson; October 22, 1999